Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Dec 21, 2014; 20(47): 17727-17736
Published online Dec 21, 2014. doi: 10.3748/wjg.v20.i47.17727
Published online Dec 21, 2014. doi: 10.3748/wjg.v20.i47.17727
Model | Disease |
Models with increased disease incidence or severity | |
β-lactoglobulin induced mouse[51] | Allergy |
NOD mouse[42] | Type 1 diabetes |
MyD88 KO NOD mouse[42] | Type 1 diabetes |
Restrained mouse[43] | Stress |
Models with decreased disease incidence or severity | |
Ovalbumin-specific TCR TG mouse[44] | Allergy |
Swiss-Webster mouse[45] | Anxiety |
Collagen induced rat[52] | Arthritis |
HLA-B27 TG rat[53] | IBD |
IL-2 KO mouse[54,55] | IBD |
IL-10 KO mouse[56] | IBD |
TCRα KO mouse[57] | IBD |
Dextran sulfate sodium induced mouse[46] | IBD |
SAMP1/Yit mouse[47] | IBD |
Adoptive T-cell transfer in the mouse[48] | IBD |
Carrageenan, LPS, or formalin induced mouse[49] | Inflammatory pain |
C57BL/6 mouse[65] | Obesity |
C57BL/6 mouse[65] | Type 2 diabetes |
- Citation: Hansen AK, Hansen CHF, Krych L, Nielsen DS. Impact of the gut microbiota on rodent models of human disease. World J Gastroenterol 2014; 20(47): 17727-17736
- URL: https://www.wjgnet.com/1007-9327/full/v20/i47/17727.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i47.17727